Skip to content

Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514054-70-00
Acronym
76712
Enrollment
14
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.

Interventions

None listed

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026